The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Rapid and efficient generation of oligodendrocytes from human induced pluripotent stem cells using transcription factors
Open accessAbstract
Significance Understanding of myelin diseases and development of new treatment options are at least partly hampered by the limited availability of human oligodendrocytes. Induced pluripotent stem cells (iPSC) may be an ideal tool to circumvent this problem; however, rapid and efficient protocols to generate oligodendrocytes from human iPSC are currently lacking. The induction of the transcription factors SOX10, OLIG2, and NKX6.2 in iPSC-derived neural progenitors accelerates oligodendroglial differentiation significantly resulting in up to 70% of O4 + oligodendrocytes within 28 d. These oligodendrocytes myelinate the CNS during development and after demyelination, and are suitable for pharmacological screens and disease modeling. The strategy presented herein will markedly facilitate the studying of human myelin diseases and the development of screening platforms for drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic sources, such as fibroblasts or peripheral blood cells, can be reprogrammed into iPS cells or directly converted into neural lineages, offering versatile platforms to model MS, PMD and other neuroinflammatory or demyelinating disorders48–55.”
From From insights to innovations: evaluating preclinical paradigms in demyelinating disease therapeutics (2026) · cites this paper as [50]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Oligodendrocytes were derived from iPSCs as previously described [17].”
From Selective suppression of oligodendrocyte-derived amyloid beta rescues neuronal dysfunction in Alzheimer’s disease (2024) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Lu, Q. R., Yuk, D.-I., Alberta, J., Zhu, Z.-M., Pawlitzky, I., Chan, J., McMahon, A., Stiles, C., & Rowitch, D. H. (2000) · Neuron · doi:10.1016/s0896-6273(00)80897-1 · Cited by 883
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis
Mei, F., Fancy, S. P. J., Shen, Y. A., Niu, J., Zhao, C., Presley, B., Miao, E., Lee, S., Mayoral, S. R., Redmond, S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3618 · Cited by 595
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586
A regenerative approach to the treatment of multiple sclerosis
Deshmukh, V. A., Tardif, V., Lyssiotis, C. A., Green, C. C., Kerman, B., Kim, H. J., Padmanabhan, K., Swoboda, J. G., Ahmad, I., Kondo, T., et al. (2013) · Nature · doi:10.1038/nature12647 · Cited by 531
Reinhardt, P., Glatza, M., Hemmer, K., Tsytsyura, Y., Thiel, C. S., Höing, S., Moritz, S., Parga, J. A., Wagner, L., Bruder, J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059252 · Cited by 461
Self-citationGhetti, B. F., Oblak, A. L., Boeve, B. F., Johnson, K. A., Dickerson, B. C., & Goedert, M. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12213 · Cited by 458
A culture system to study oligodendrocyte myelination processes using engineered nanofibers
Lee, S., Leach, M. K., Redmond, S., Chong, S. Y. C., Mellon, S. H., Tuck, S. J., Feng, Z. Q., Corey, J. M., & Chan, J. R. (2012) · Nature Methods · doi:10.1038/nmeth.2105 · Cited by 455
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–258 of 258
Using iPSC models to examine neuron–glia interactions in neurodegenerative diseases
Lopez, D. M., Keavey, L., & Bowles, K. R. (2026) · Bioscience Reports · doi:10.1042/bsr20250131 · Cited by 2
Translating Alzheimer’s disease proteomics into drug discovery opportunities
Drummond, E., Werry, E. L., Kavanagh, T., Genoud, S., Cho, A., Chen, S., Du, J., Hibbs, D. E., & Kassiou, M. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00035-y · Cited by 2
Modeling rare pediatric neurogenetic disorders with IPSCs
Kim, J., Nonis, D., Otero, M. G., & Pierson, T. M. (2019) · AIMS Cell and Tissue Engineering · doi:10.3934/celltissue.2019.1.1 · Cited by 2
Bipolar disorder as a gliopathy
Stertz, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00015-6 · Cited by 2
Glial cell transplant for brain diseases: the supportive saviours?
Albert, K., Goldsteins, G., Kälvälä, S., Jolkkonen, J., & Lehtonen, Š. (2024) · Translational Medicine Communications · doi:10.1186/s41231-024-00182-y · Cited by 3
Back, A. M., Connor, B. J., & McCaughey‐Chapman, A. (2024) · Journal of Neuroscience Research · doi:10.1002/jnr.70010 · Cited by 3
Pascual-Guerra, J., Torres-Rico, M., Marín-Rodríguez, B., Arasmou-Idrovo, M. S., Garcı́a, A. G., Rodríguez-Navarro, J. A., & Paı́no, C. L. (2025) · Cells · doi:10.3390/cells14070533 · Cited by 2
Cellular and molecular neurobiology of autism spectrum disorder
Chapman, G., Antony, I., Narasimhan, M., Shen, R., Elman, R., & Kroll, K. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-816393-1.00007-5 · Cited by 2
In vitro models for human neuroglia
Lendemeijer, B., & de Vrij, F. M. S. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19104-6.00015-2 · Cited by 1
Establishing validity standards for iPSC modeling of neuropsychiatric disorders
Kolsters, N., Vernon, A. C., Kasri, N. N., & Latour, B. L. (2025) · Genomic psychiatry : · doi:10.61373/gp025p.0074 · Cited by 1
Alpha synuclein-mediated cytoskeletal dysfunction impairs myelination in human oligodendrocytes
Wihan, J., Battis, K., Hoffmann, A., Windener, F., Himmler, M., Varghese, A., Koller, A., Karnatz, I., Schubert, D. W., Zunke, F., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02933-z · Cited by 1
Self-citationCharacterising processing conditions that artifactually bias human brain tissue transcriptomes
Yaqubi, M., Thomas, M., Talbot-Martin, J., Mohammadnia, A., Allot, A., Groh, A. M. R., Fancy, N. N., Papageorgopoulou, M., Zhang, X., McGarry, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68872-9 · Cited by 2
Xin, J., Liu, J., Dong, H.-M., Yu, H., Xiao, Z., Hu, J.-N., Jiang, Q., Zhu, Y.-P., Feng, L., Feng, Y., et al. (2026) · Science China Life Sciences · doi:10.1007/s11427-025-3243-2 · Cited by 2
Park, J., Kang, S., Kim, S., Kim, D., Shin, B., Mun, J. Y., Park, Y., Kim, J., Goldman, S. A., & Kim, K.-P. (2026) · Cells · doi:10.3390/cells15121067 · Cited by 1
Self-citationOrganoids: the third dimension of human brain development and disease
Kouroupi, G., Prodromidou, K., Papastefanaki, F., Taoufik, E., & Matsas, R. (2021) · The International Journal of Developmental Biology · doi:10.1387/ijdb.210158gk · Cited by 1
Bertero, A., Coccini, T., & Caloni, F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00022-0 · Cited by 1
Human neural stem cells in developmental neurotoxicology: Current scenario and future prospects
(2023) · Advances in neurotoxicology · doi:10.1016/bs.ant.2023.01.005 · Cited by 1
Tang, X., Yu, M., Liao, C., Lan, S., & Fan, Y. (2020) · Connective Tissue Research · doi:10.1080/03008207.2019.1670651 · Cited by 2
The therapeutic potential of exogenous adult stem cells for the injured central nervous system
Smith, J. A., Braga, A., Hamel, R., Rutigliani, C., Yu, B., Peruzzotti‐Jametti, L., & Pluchino, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818084-6.00006-4 · Cited by 1
Lam, G., Shea, G. K., Wu, L. K., Sui, M. L. T., Hei, K. C., Chan, Z. C.-K., Yin, Y. W. C., Tsui, A. Y. P., Shum, D. K., & Chan, Y. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/658997 · Cited by 1
Martínez-Curiel, R., Jansson, L., Tsupykov, O., Avaliani, N., Aretio-Medina, C., Hidalgo, I., Monni, E., Bengzon, J., Skibo, G. G., Lindvall, O., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.24.534133 · Cited by 1
Yang, X., Mayoral, S., Jiang, Y.-H., Marshall, J., & Huang, Y. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.21.726878 · Cited by 1
Young, J. E., & Delgado‐Morales, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_1
Remyélinisation du système nerveux central et sclérose en plaques
Dubessy, A., & Stankoff, B. (2019) · Elsevier eBooks · doi:10.1016/b978-2-294-71420-7.00007-0
Pessôa, L. V. D. F., Chandrasekaran, A., Thomsen, B. B., Berendt, M., Hyttel, P., & Freude, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822228-7.00010-2
Sonninen, T.-M., Plotnikova, L. M., Laham-Karam, N., Goldsteins, G., Koıstınaho, J., & Lehtonen, Š. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00009-0
Singer, P. (2003) · Claves de razón práctica
Wulansari, W., Torizal, F. G., Khumaira, A., & Nugraheni, I. A. (2022) · JHeS (Journal of Health Studies) · doi:10.31101/jhes.1730
Popko, B., & Elbaz, B. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732782888.793552935
PLURİPOTENT KÖK HÜCRELERDEN SİNİR HÜCRELERİNE FARKLILAŞTIRMA YÖNTEMLERİ
Kuruş, M., Ergin, K., & Çetinkaya, R. (2022) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.1103596 · Cited by 2
Chou, H., Mao, X., & Ying, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822277-5.00003-1
Oun, A. (2022) · doi:10.33612/diss.253651629
Models of Neurodegenerative Diseases
Maharjan, N., & Saxena, S. (2022) · Learning materials in biosciences · doi:10.1007/978-3-031-07793-7_10 · Cited by 1
Bennett, I., & Joykutty, L. (2021) · Journal of Emerging Investigators · doi:10.59720/20-025
von der Bey, M., & Ercan-Herbst, E. (2023) · Journal of Neurology and Neuromedicine · doi:10.29245/2572.942x/2023/2.1290
Oligodendrocytes in multiple sclerosis
Pernin, F., Kuhlmann, T., Kennedy, T. E., & Antel, J. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-823848-6.00009-9
Self-citationAskar, I. C., Spenlé, C., & Bagnard, D. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2382180
An Efficient Electroporation Protocol Supporting In Vitro Studies of Oligodendrocyte Biology
Ishino, Y., Shimizu, S., & Miyata, S. (2025) · Methods and Protocols · doi:10.3390/mps8030064
Gerhards, R., Pfeffer, L. K., Lorenz, J., Starost, L. J., Nowack, L., Thaler, F., Schlüter, M., Rübsamen, H., Macrini, C., Winklmeier, S., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13311369
Self-citationSupakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686686
Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686680
Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686683
Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686677
McInvale, J. J., Ayers, C. E., Sarmah, H., Kim, K., Reinhardt, P., Mahajan, A., Humala, N., Corneo, B., Sterneckert, J. L., Canoll, P., et al. (2026) · STAR Protocols · doi:10.1016/j.xpro.2025.104305
Self-citationParameswaran, S. (2026) · Current Protocols · doi:10.1002/cpz1.70320
Alemany‐Ribes, M., Pérez‐Soriano, A., Santos, A., Severino, J., Dangla-Valls, A., Gigirey-Suárez, M., Cohen, D., Ezquerra, M., Fernandez-Santiago, R., Fernández, M., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1641981
Kumar, P. P., & Kumar, S. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-6274-8.ch008
Ishikawa, M., Izumizawa, Y., Supakul, S., & Okano, H. (2026) · Genes to Cells · doi:10.1111/gtc.70106
Pharmacogenomic identification of small molecules promoting oligodendrogenesis and myelin repair
Huré, J.-B. (2022) · theses.fr (ABES) · doi:10.70675/17691e80z7bacz455fzba89z49fef7be0512
Morita, S., Kondo, T., Imamura, K., Sagara, Y., Tsukita, K., Tokuda, H., Kaneda, Y., Izumo, T., Nakao, Y., & Inoue, H. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.102923
Byrne, A., Hoover, J., Lund, J. M., Zhang, A., Shan, X., Sharma, A. D., Chen, X., Xavier‐Magalhães, A., Phu, L., Choi, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.724443 · Cited by 2
Karmali, N., Kessler, W., Dehestani, M., Sun, W., Drwesh, L., Volos, P., Tsitkov, S., Dhingra, A., Thomas, C., Rodrı́guez-Nieto, S., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116368 · Cited by 3
Self-citationPlaque-associated oligodendrocyte proteostatic failure underlies myelin loss in Alzheimer’s diseasePreprint
Shin, J., Joshi, N., Miller, B., Vellarikkal, S., Huang, J., Wu, F., Cui, Y., Murali, A., Chason, J., Campbell, C. S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.08.737318
Bienjonetti, I., Roy, V., Beaudet, M., Louit, A., Martineau, L., Berthod, F., Dupré, N., & Gros‐Louis, F. (2026) · Journal of Neuroscience Research · doi:10.1002/jnr.70155
Multicellular Co-development Promotes Maturation of Human Stem Cell-Derived Neural NetworksPreprint
Čarná, M., Feole, M., Devoto, V. M. P., Novotný, J., Klosterman, K. E., Jurič, D. M., Jáuregui, G. V., Dragišić, N., Srt, L., Salem, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10956881/v1
HONG, Y., Ming, G.-L., & SONG, H. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19043-8.00002-5
Metadata
- Authors
- Ehrlich, M., Mozafari, S., Glatza, M., Starost, L., Velychko, S., Hallmann, A.-L., Cui, Q.-L., Schambach, A., Kim, K.-P., Bachelin, C., Marteyn, A., Hargus, G., Johnson, R. M., Antel, J., Sterneckert, J., Zaehres, H., Schöler, H. R., Baron-Van Evercooren, A., & Kuhlmann, T.
- Affiliations
- University Hospital Münster (DE)
- Centre National de la Recherche Scientifique (FR)
- Max Planck Institute for Molecular Biomedicine (DE)
- Montreal Neurological Institute and Hospital (CA)
- Medizinische Hochschule Hannover (DE)
- McGill University (CA)
- Center for Regenerative Therapies Dresden (DE)
- University of Münster (DE)
- INSERM, U1127, F-75013 Paris, France;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2017-02-28
- Volume
- 114
- Issue
- 11
- Pages
- E2243-E2252
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC5358375
- OpenAlex
- W2592644893
- Cited by
- 257
- References
- 51
- Citations by year
- 2026: 21 · 2025: 27 · 2024: 26 · 2023: 25 · 2022: 39 · 2021: 28 · 2020: 35 · 2019: 31 · 2018: 19 · 2017: 5
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-11-INBS-0011)
- National Institute of Neurological Disorders and Stroke (R25NS070697)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Keywords
- oligodendrocyte differentiation, induced pluripotent stem cells, transcription factors, SOX10, Olig2, NKX6-2, myelination, myelin diseases, demyelination, neural progenitor cells, disease modeling, drug discovery screening
- MeSH terms
- Ectopic Gene Expression, Animals, Brain, Cell Differentiation, Cells, Cultured, Demyelinating Diseases, Disease Models, Animal, Myelin Basic Protein, Humans, Mutation, Myelin Sheath, Oligodendroglia, Spinal Cord, Transcription Factors, Biomarkers, Cluster Analysis, tau Proteins, Cell Death, Oxidative Stress, Cell Lineage, Gene Expression Profiling, Mice, Induced Pluripotent Stem Cells, Neural Stem Cells, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review